Figlin RA - Search Results

1

Renal cell carcinoma therapy in 2010: many options with little comparative data.

Pal SK, Figlin RA. Pal SK, et al. Among authors: figlin ra. Clin Adv Hematol Oncol. 2010 Mar;8(3):191-200. Clin Adv Hematol Oncol. 2010. PMID: 20400934 Review.

2

Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.

Figlin RA, Belldegrun A, Moldawer N, Zeffren J, deKernion J. Figlin RA, et al. J Clin Oncol. 1992 Mar;10(3):414-21. doi: 10.1200/JCO.1992.10.3.414. J Clin Oncol. 1992. PMID: 1482425 Clinical Trial.

3

Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.

Figlin RA, Pierce WC, Belldegrun A. Figlin RA, et al. Semin Oncol. 1993 Dec;20(6 Suppl 9):11-5. Semin Oncol. 1993. PMID: 8284686 Review. No abstract available.

4

Renal cell carcinoma: management of advanced disease.

Figlin RA. Figlin RA. J Urol. 1999 Feb;161(2):381-6; discussion 386-7. doi: 10.1016/s0022-5347(01)61897-4. J Urol. 1999. PMID: 9915408 Review.

5

Adoptive cellular therapy.

Hoffman DM, Gitlitz BJ, Belldegrun A, Figlin RA. Hoffman DM, et al. Among authors: figlin ra. Semin Oncol. 2000 Apr;27(2):221-33. Semin Oncol. 2000. PMID: 10768601 Review.

6

Improved prognostication of renal cell carcinoma using an integrated staging system.

Zisman A, Pantuck AJ, Dorey F, Said JW, Shvarts O, Quintana D, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS. Zisman A, et al. Among authors: figlin ra. J Clin Oncol. 2001 Mar 15;19(6):1649-57. doi: 10.1200/JCO.2001.19.6.1649. J Clin Oncol. 2001. PMID: 11250993

7

Mathematical model to predict individual survival for patients with renal cell carcinoma.

Zisman A, Pantuck AJ, Dorey F, Chao DH, Gitlitz BJ, Moldawer N, Lazarovici D, deKernion JB, Figlin RA, Belldegrun AS. Zisman A, et al. Among authors: figlin ra. J Clin Oncol. 2002 Mar 1;20(5):1368-74. doi: 10.1200/JCO.2002.20.5.1368. J Clin Oncol. 2002. PMID: 11870181

8

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.

Zisman A, Pantuck AJ, Wieder J, Chao DH, Dorey F, Said JW, deKernion JB, Figlin RA, Belldegrun AS. Zisman A, et al. Among authors: figlin ra. J Clin Oncol. 2002 Dec 1;20(23):4559-66. doi: 10.1200/JCO.2002.05.111. J Clin Oncol. 2002. PMID: 12454113

9

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.

Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, DePrimo SE, Li JZ, Bello CL, Theuer CP, George DJ, Rini BI. Motzer RJ, et al. Among authors: figlin ra. J Clin Oncol. 2006 Jan 1;24(1):16-24. doi: 10.1200/JCO.2005.02.2574. Epub 2005 Dec 5. J Clin Oncol. 2006. PMID: 16330672 Clinical Trial.

10

Renal cell carcinoma: the translation of biology to clinical application.

Figlin RA. Figlin RA. Semin Oncol. 2006 Oct;33(5):525-6. doi: 10.1053/j.seminoncol.2006.08.008. Semin Oncol. 2006. PMID: 17045080 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters